Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. UPS (UPS) downgraded to Market Perform from Outperform at BMO Capital with analyst Fadi Chamoun saying the company's path to improving its profitability and free cash flow is challenging. 2. Dentsply Sirona (XRAY) downgraded to Neutral from Overweight at JPMorgan with analyst Tycho Peterson while the company should continue benefiting from new products, restructuring-related cost savings and a generally conservative approach to guidance, comps are set to get tougher in 2020. 3. Walgreens downgraded to Market Perform from Outperform at Wells Fargo with analyst Peter Costa saying Wells Fargo's new rating parameters focus on relative performance compared to the group, while previously it focused on comparison to the market as a whole. 4. Cigna (CI) downgraded to Underperform from Market Perform at Wells Fargo with analyst Peter Costa saying he believes Cigna's "large" debt load could impede its growth and upside earnings surprises. 5. Prosperity Bancshares (PB) downgraded to Underperform from Market Perform at Hovde Group. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.  1... To see the rest of the story go to thefly.com. See Story Here

Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.  1... To see the rest of the story go to thefly.com. See Story Here

Unusual total active option classes on open include: ImmunityBio (IBRX), Halliburton (HAL), Redfin (RDFN), Nokia (NOK), Matterport (MTTR), General Motors (GM), UPS (UPS), Philip Morris (PM), PepsiCo (PEP), and General Electric (GE).

UPS says it is early in the process and will share progress on pension considerations when appropriate.

For 2024, UPS reaffirms its full-year, consolidated financial targets: Consolidated revenue to range from approximately $92.0 billion to $94.5 billion; Consolidated adjusted operating margin to range from approximately 10.0% to 10.6%; Capital expenditures of approximately $4.5 billion.